Bladder prolapse through a patent urachus presenting as an umbilical mass in the newborn: characteristic prenatal sonographic findings and the diagnostic benefit of postnatal cystography

We report a case of bladder prolapse through a patent urachus in a term male neonate with a large, red, tubular, mucosa lined mass inferior to the umbilical cord. A cystic mass communicating with fetal urinary bladder was detected in an antenatal ultrasound in a 26 years primigravida at 18 and 26 weeks gestation. The cyst disappeared at 35 weeks and a new solid mass was noted at the fetal abdominal wall. After birth a protruded mucosal mass inferior to the umbilical cord was noted. Urethral catherisation confirmed communication with bladder. On the second day of life excision of urachus, repair, reduction of bladder and reconstruction of abdominal wall was performed. The patient voided well and was discharged on ninth day without any complication. DOI: http://dx.doi.org/10.3126/jnps.v34i1.7877 J Nepal Paediatr Soc 2014;34(1):68-70

Download Full-text

DNA Testing Proves of Diagnostic Benefit in Genodermatoses

Family Practice News ◽

10.1016/s0300-7073(05)71322-0 ◽

2005 ◽

Vol 35 (3) ◽

pp. 40

Author(s):

BETSY BATES

Keyword(s):

Dna Testing ◽

Diagnostic Benefit

Download Full-text

[18F]Fluoride PET Indicates Reduced Bone Formation in Severe Glucocorticoid-induced Osteoporosis

Nuklearmedizin ◽

10.1055/s-0038-1629797 ◽

1998 ◽

Vol 37 (02) ◽

pp. 76-79 ◽

Cited By ~ 8

Author(s):

T. D. Kirchhoff ◽

W. Burchert ◽

J. v. d. Hoff ◽

H. Zeidler ◽

H. Hundeshagen ◽

...

Keyword(s):

Bone Formation ◽

Multiple Organ ◽

High Dose ◽

Multiple Fractures ◽

Glucocorticoid Treatment ◽

Organ Manifestations ◽

Diagnostic Benefit ◽

Sharp Syndrome ◽

18F Fluoride

SummaryA 61-year-old female patient presenting with mixed connective tissue disease (Sharp syndrome), underwent a long-term high dose glucocorticoid treatment because of multiple organ manifestations. Under steroid therapy she developed severe osteoporosis resulting in multiple fractures. A dynamic [18F]fluoride PET study in this patient revealed reduced fluoride influx in non-fractured vertebrae. This finding corresponds to pathogenetic concepts which propose an inhibition of bone formation as major cause of glucocorticoid-induced osteoporosis. In the light of the presented case it seems to be promising to evaluate the diagnostic benefit of [18F]fluoride PET in osteoporosis.

Download Full-text

Bladder prolapse through a patent urachus presenting as an umbilical mass in the newborn: characteristic prenatal sonographic findings and the diagnostic benefit of postnatal cystography

Prenatally diagnosed patent urachus with bladder prolapse: Case Report and review of the literature

SonoAVC: a new tool in early diagnosis of patent urachus with bladder prolapse

Postnatal Management of Antenatally Diagnosed Patent Urachus with Bladder Prolapse

Congenital Bladder Prolapse through a Patent Urachus: Two Institutions’ Experience

Bladder prolapse through a patent urachus: fetal and neonatal features

Prenatally diagnosed patent urachus with bladder prolapse

Patent urachus with bladder prolapse

Patent Urachus with Bladder Prolapse

DNA Testing Proves of Diagnostic Benefit in Genodermatoses

[18F]Fluoride PET Indicates Reduced Bone Formation in Severe Glucocorticoid-induced Osteoporosis

Export Citation Format